Knockdown of PTK6 expression by shRNA or siRNA in tumor cells leads to significant inhibition of tumor growth, induction of tumor cell apoptosis, and suppression of metastases of triple negative breast cancer, while overexpression of PTK6 promotes cell proliferation [14–18]. The gene discussed is PTK6; the disease is neoplasm.